Asthma in children Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=278 Year: 2003
Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
Bronchodilator effect of a novel inhaled dual PDE3/4 inhibitor, RPL554, in mild allergic asthma & rhinitis Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013
Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015
Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis Source: Annual Congress 2013 –Asthma Year: 2013
Risk factors of frequent exacerbations in difficult-to-treat asthma Source: Eur Respir J 2005; 26: 812-818 Year: 2005
Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015
Asthma exacerbations in relation to severe asthma Source: Eur Respir Mon 2011; 51: 120-129 Year: 2011
Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013
Treatment of asthma the current European perspective Source: Annual Congress 2006 - Childhood asthma therapy: where we are now and where we need to go Year: 2006
Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Epidemiology of asthma, allergy and bronchial hyperresponsiveness in sports Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=1 Year: 2005
IL-17A in severe asthma, severe asthma with fungal sensitisation and ABPA Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015
Clinical experience with montelukast plus ICS vs. only ICS in non-asthmatic eosinophilic bronchitis (NAEB) in Indian patients Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016
Gender differences in patients with aspirin-induced asthma (AIA) Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
Chronic rhinosinusitis and the prevalence of asthma Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013
Asthma among allergic rhinitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 108s Year: 2003
Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016